Huisheng Biopharmaceutical
Jilin
About Huisheng Biopharmaceutical
Huisheng Bio is a diabetes and complication treatment solution provider. The company was founded in 2019 and is headquartered in Jilin, China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $158.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2023)
- Website: huishengpharm.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/huisheng-biopharmaceutical-188753 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.